COMPANY
TAPI NL BV
TAPI NL BV: API manufacturer for Carfilzomib, Desmopressin, Exenatide, Icatibant, Linaclotide, Octreotide, Semaglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Carfilzomib | DMF 30124, type II, active, submitted 2016-01-21 Regulator FDA drug master file list |
|---|---|
| Desmopressin | DMF 16947, type II, active, submitted 2003-11-07 Regulator FDA drug master file list |
| Exenatide | DMF 27123, type II, active, submitted 2013-07-07 Regulator FDA drug master file list |
| Icatibant | DMF 30476, type II, active, submitted 2016-06-09 Regulator FDA drug master file list |
| Linaclotide | DMF 30274, type II, active, submitted 2016-03-10 Regulator FDA drug master file list |
| Octreotide | DMF 17777, type II, active, submitted 2004-10-21 Regulator FDA drug master file list |
| Semaglutide | DMF 42108, type II, active, submitted 2025-12-10 Regulator FDA drug master file list |
| Tirzepatide | DMF 42369, type II, active, submitted 2025-12-15 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.